Stewart Richard Alistair sold $175K of ACHV
Stewart Richard Alistair sold 20,626 shares of ACHIEVE LIFE SCIENCES, INC. (ACHV) at $8.49 ($0.18M total) on 2026-08-19.
How this was made
The 30-second read
Why it matters
The disclosed sale reduces the director's ownership but remains a small portion of total shares outstanding, likely limiting market impact.
Market read
Provides fresh insider transaction data for ACHV, useful for short‑term traders monitoring insider sentiment.
What to watch
Potential upcoming corporate events or financing needs not disclosed.
Background
Form 4 filings disclose insider transactions and are required by the SEC for transparency.
Ticker impact
Director Stewart Richard Alistair sold 20,626 shares of ACHV for $175,176, reducing his stake to 208,249 shares.
Potential slight downward pressure on ACHV price in the short term.
The sale represents a small fraction of the insider's total position and is typical for liquidity needs; market reaction is likely limited.
Market effects
Minimal impact on the biotech sector; insider activity is company‑specific.
No broader regional effect.
Limited to investors tracking ACHV.
Counterpoint
The sale could be a routine liquidity move, not a negative signal.
Key entities
- DirectorStewart Richard Alistair
Director of Achieve Life Sciences, Inc. who sold shares.
- CompanyAchieve Life Sciences, Inc.
Biotech company listed on NASDAQ under ticker ACHV.
